Incidence and prognosis of COVID‐19 in patients with psoriasis on apremilast: a multicentre retrospective cohort study
Yuliya Lytvyn(University Health Network), Jensen Yeung(Sunnybrook Health Science Centre), Perla Lansang(Sunnybrook Health Science Centre), Vipul Jain(McMaster University), Vimal H. Prajapati(University of Calgary), Alim R Devani(SKiN Health), Asfandyar Mufti(University of Toronto), Ronald Vender(Dermatrials Research), Jorge R. Georgakopoulos(University of Toronto), Melinda Gooderham(Queen's University)
Cited by 7
Related Papers
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis
|JAMA Dermatology|2019|516
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial
|Journal of the American Academy of Dermatology|2020|396
Glycosuria-mediated urinary uric acid excretion in patients with uncomplicated type 1 diabetes mellitus
|American Journal of Physiology-Renal Physiology|2014|173
The New Biology of Diabetic Kidney Disease—Mechanisms and Therapeutic Implications
|Endocrine Reviews|2019|171